The Chinese government should be facing the reckoning of all reckonings for its actions and inactions that caused and worsened this pandemic. It hasn’t.
Canada needs to be ‘less hostile and more grateful’ to the pharmaceutical industry: Richard Owens explains why
Policy thinker Richard Owens joins Hub Dialogues to dispel the myths around the benefits of price controls in the pharmaceutical industry and outline why Canada needs to get rid of the Patented Medicine Prices Review Board.
With more and more people catching and recovering from COVID-19, fears about long-COVID symptoms that persist for months can be hard to shake.
Reforming Canada’s ‘rigid’ health system: Medtronic President Neil Fraser on why patient-centric care is so important
Neil Fraser, the Canadian President of Medtronic, joins Hub Dialogues to discuss the world of medical technology, the role of public policy in health, and the future that he sees for leveraging new technologies to improve health outcomes.
Politicians have been all-too-happy to embrace the rhetorical dodge of “following the science”. By pinning the responsibility for their decisions on “the science”, they avoid having to explain the true reasoning, which might open them up to criticism and debate.
How a system functions has more to do with how its governed than with the policy ideas in play. Implementation failure, constraints, and incentives all fall under the larger umbrella of governance.
Freeland battles the inflation fire: The Hub Roundtable on the government’s response to our economic troubles
This week’s Hub Dialogue Roundtable discusses Finance Minister Chrystia Freeland’s speech this week to the Empire Club in Toronto where she announced measures in response to growing inflation. Will it work?
Quebec’s outdated and inefficient systems make it needlessly difficult for researchers to access data. And more importantly, Quebeckers deserve easily accessible medical history for patients and clinicians, writes Maria Lily Shaw and Krystle Wittevrongel.
Canada’s harm reduction strategy to battle drug overdoses is a failure. Casualties continue to climb. The enemy is winning. It’s getting worse and there’s no end in sight.
High-quality universal health care can be preserved with extra funding targeted to those providing direct patient contact and the use of cost-saving innovation.